Tebentafusp in the treatment of metastatic uveal melanoma - the first patient treated in the Czech Republic
{{output}}
Background: Uveal melanoma is a rare cancer, in which metastases occur in approximately one half of cases. In metastatic disease, the prognosis is unfavorable and the median of survival does not exceed 6 months. Effective treatme... ...
